| HOME >> BIOLOGY >> TECHNOLOGY |
About PAREXEL International
PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 69 locations throughout 52 countries around the world, and has approximately 8,800 employees. For more information about PAREXEL International visit http://www.PAREXEL.com.
This release contains "forward-looking" statements regarding future
results and events. For this purpose, any statements contained herein that
are not statements of historical fact may be deemed forward-looking
statements. Without limiting the foregoing, the words "believes,"
"anticipates," "plans," "expects," "intends," "appears," "estimates,"
"projects," "targets," and similar expressions are also intended to
identify forward-looking statements. The forward-looking statements in this
release involve a number of risks and uncertainties. The Company's actual
future results may differ significantly from the results discussed in the
forward-looking statements contained in this release. Important factors
that might cause such a difference include, but are not
'/>"/>
| SOURCE PAREXEL International Copyright©2008 PR Newswire. All rights reserved |